Myocardial Disease - Hypertrophic Obstructive Cardiomyopathy Flashcards
What is Hypertrophic Obstructive Cardiomyopathy?
Autosomal Dominant disorder of muscle tissue caused by defects in genes encoding contractile proteins.
Associations of Hypertrophic Obstructive Cardiomyopathy.
- Friedrich’s Ataxia.
2. Wolff-Parkinson White.
Pathophysiology of Hypertrophic Obstructive Cardiomyopathy.
- Commonest Defect : Mutation in Gene encoding B-Myosin Heavy Chain Protein or Myosin-Binding Protein C.
- Predominantly Diastolic Dysfunction (LV Hypertrophy - Decreased Compliance - Decreased CO).
- Myofibrillar Hypertrophy with Chaotic and Disorganised Fashion Myocytes (‘Disarray’) and Fibrosis on Biopsy.
Clinical Features of Hypertrophic Obstructive Cardiomyopathy.
- Asymptomatic.
- Exertional Dyspnoea.
- Angina.
- Syncope following Exercise (Subaortic Hypertrophy of Ventricular Septum - Functional Aortic Stenosis).
- Sudden Death (Ventricular Arrhythmias).
- Jerky Pulse, Large A Waves, Double Apex Beat.
Describe the murmur in Hypertrophic Obstructive Cardiomyopathy
- Ejection Systolic Murmur.
- Increases with Valsalva Manoeuvre.
- Decreases with Squatting.
- Impaired Mitral Valve Closure - can cause regurgitation.
ECG Findings in Hypertrophic Obstructive Cardiomyopathy.
- LV Hypertrophy.
- Non-Specific ST and T Wave Abnormalities - Progressive T Wave Inversion.
- Deep Q Waves.
ECHO Findings in Hypertrophic Obstructive Cardiomyopathy.
MR. SAM ASH :
- Mitral Regurgitation (MR).
- Systolic Anterior Motion of Anterior Mitral Valve Leaflet (SAM).
- Asymmetric Hypertrophy (ASH).
Management of Hypertrophic Obstructive Cardiomyopathy (5).
ABCDE :
- A - Amiodarone.
- B - B-Blockers/Verapmil.
- C - Cardioverter Defibrillator.
- D - Dual Chamber Pacemaker.
- E - Endocarditis Prophylaxis.
What 3 drugs must be avoided in Hypertrophic Obstructive Cardiomyopathy?
- Nitrates.
- ACE Inhibitors.
- Inotropes.
Prognosis of Hypertrophic Obstructive Cardiomyopathy.
Sudden Death - Ventricular Arrhythmia (VT due to Ischaemia).